Protagenic Therapeutics, Inc. (13)

Browse by Contract Category

Contracts

At Market Issuance Sales Agreement, dated as of July 2, 2021, by and between Protagenic Therapeutics, Inc., B. Riley Securities, Inc. and EF Hutton, division of Benchmark... (Filed With SEC on July 2, 2021)
5.00% Promissory Note (Filed With SEC on May 17, 2021)
Consulting Agreement, effective December 18, 2020, between Protagenic Therapeutics Inc. and Dr. Andrew Slee (Filed With SEC on March 25, 2021)
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on April 29, 2020)
Underwriting Agreement dated April 26, 2021, by and among the Company and Kingswood Capital Markets, division of Benchmark Investments, Inc,as representative of the underwriters (Filed With SEC on April 30, 2021)
Form of Warrant (included in Exhibit 10.15) (Filed With SEC on April 26, 2021)
Form of Warrant (included in Exhibit 10.15) (Filed With SEC on April 23, 2021)
Form of Underwriting Agreement (Filed With SEC on April 9, 2021)
Form of Warrant (included in Exhibit 10.15) (Filed With SEC on April 9, 2021)
Amended and Restated Consulting Agreement, effective December 18, 2020, between Protagenic Therapeutics Inc. and Dr. Robert B. Stein (Filed With SEC on March 25, 2021)
Form of Convertible Note Purchase Agreement (Filed With SEC on November 21, 2019)
Form of Convertible Promissory Note (Filed With SEC on November 21, 2019)
Form of Guaranty (Filed With SEC on November 21, 2019)